Swiss stocks - Factors to watch on February 2

Allarity Therapeutics

02/02/2024 05:50

ZURICH/BERLIN, Feb 2(Reuters) - Here are some of the
main factors that may affect Swiss stocks on Friday:
     
    COMPANY NEWS
    Allarity Therapeutics  ALLR.O  said on Thursday it received
written notice from Novartis  NOVN.S  indicating their decision
to terminate a licence agreement based on material breach for
lack of financial payment. The termination took effect on
January 26, 2024, Allarity said.
    
    ANALYSTS' VIEWS
    JULIUS BAER GRUPPE AG  BAER.S : HSBC CUTS TARGET PRICE TO
CHF 60 FROM CHF 62 
    LONZA GROUP AG  LONN.S : JP MORGAN RAISES TARGET PRICE TO
CHF 500 FROM CHF 450     
    
    ECONOMY
    No major Swiss economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))